Dermatology OTC medications Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Dermatology OTC medications market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.7% during the forecast period.

    This report presents the market size and development trends by detailing the Dermatology OTC medications market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Dermatology OTC medications market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Dermatology OTC medications industry and will help you to build a panoramic view of the industrial development.

    Dermatology OTC medications Market, By Type:

    • Sun screens

    • Anti-aging

    • Wrinkle cream

    • Acne Treatment

    • others

    Dermatology OTC medications Market, By Application:

    • male

    • female

    Some of the leading players are as follows:

    • Clarins

    • Clinique Laboratories

    • Sisley Paris

    • Shiseido

    • Revlon

    • Edgewell Personal Care

    • Lancaster Beauty

    • Lotus Herbals

    • Avon Products

    • Obagi Medical Products

    • Beiersdorf

    • Amway

    • Bayer

    • COOLA SUNCARE

    • Proctor & Gamble

    • Johnson & Johnson

    • Sebapharma

    • Avene

    • loreal

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Dermatology OTC medications Market: Technology Type Analysis

    • 4.1 Dermatology OTC medications Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Dermatology OTC medications Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Sun screens

      • 4.3.2 Anti-aging

      • 4.3.3 Wrinkle cream

      • 4.3.4 Acne Treatment

      • 4.3.5 others

    5 Dermatology OTC medications Market: Product Analysis

    • 5.1 Dermatology OTC medications Product Market Share Analysis, 2018 & 2026

    • 5.2 Dermatology OTC medications Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Dermatology OTC medications Market: Application Analysis

    • 6.1 Dermatology OTC medications Application Market Share Analysis, 2018 & 2026

    • 6.2 Dermatology OTC medications Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 male

      • 6.3.2 female

    7 Dermatology OTC medications Market: Regional Analysis

    • 7.1 Dermatology OTC medications Regional Market Share Analysis, 2018 & 2026

    • 7.2 Dermatology OTC medications Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Clarins

      • 9.1.1 Clarins Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Clinique Laboratories

      • 9.2.1 Clinique Laboratories Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Sisley Paris

      • 9.3.1 Sisley Paris Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Shiseido

      • 9.4.1 Shiseido Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Revlon

      • 9.5.1 Revlon Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Edgewell Personal Care

      • 9.6.1 Edgewell Personal Care Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Lancaster Beauty

      • 9.7.1 Lancaster Beauty Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Lotus Herbals

      • 9.8.1 Lotus Herbals Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Avon Products

      • 9.9.1 Avon Products Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Obagi Medical Products

      • 9.10.1 Obagi Medical Products Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Beiersdorf

      • 9.11.1 Beiersdorf Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Amway

      • 9.12.1 Amway Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Bayer

      • 9.13.1 Bayer Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 COOLA SUNCARE

      • 9.14.1 COOLA SUNCARE Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Proctor & Gamble

      • 9.15.1 Proctor & Gamble Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Johnson & Johnson

      • 9.16.1 Johnson & Johnson Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Sebapharma

      • 9.17.1 Sebapharma Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 Avene

      • 9.18.1 Avene Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 loreal

      • 9.19.1 loreal Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

     

    The List of Tables and Figures (Totals 76 Figures and 140 Tables)

    • Figure Sun screens Dermatology OTC medications market, 2015 - 2026 (USD Million)

    • Figure Anti-aging Dermatology OTC medications market, 2015 - 2026 (USD Million)

    • Figure Wrinkle cream Dermatology OTC medications market, 2015 - 2026 (USD Million)

    • Figure Acne Treatment Dermatology OTC medications market, 2015 - 2026 (USD Million)

    • Figure others Dermatology OTC medications market, 2015 - 2026 (USD Million)

    • Figure male market, 2015 - 2026 (USD Million)

    • Figure female market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Dermatology OTC medications market, by country, 2015 - 2026 (USD Million)

    • Table North America Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table North America Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table North America Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Canada Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Canada Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Europe Dermatology OTC medications market, by country, 2015 - 2026 (USD Million)

    • Table Europe Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Europe Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Europe Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Germany Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Germany Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table France Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table France Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Italy Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Italy Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Spain Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Spain Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dermatology OTC medications market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table China Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table China Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Japan Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Japan Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table India Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table India Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Dermatology OTC medications market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table MEA Dermatology OTC medications market, by country, 2015 - 2026 (USD Million)

    • Table MEA Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table MEA Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table MEA Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Dermatology OTC medications market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Dermatology OTC medications market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Dermatology OTC medications market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Clarins Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Clinique Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sisley Paris Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shiseido Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Revlon Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Edgewell Personal Care Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lancaster Beauty Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lotus Herbals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Avon Products Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Obagi Medical Products Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Beiersdorf Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amway Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table COOLA SUNCARE Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Proctor & Gamble Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sebapharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Avene Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table loreal Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.